Moreover, STK11 mutations often coexist with KEAP1 mutations that relate to cellular resistance to oxidative stress [71], and co-occurrence of KEAP1 mutations and PTEN inactivation is an indicator of an immunologically “cold” tumor [72]. Here, STK11 is linked to neoplasm.